{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T04:37:42Z","timestamp":1719895062593},"reference-count":66,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Clin Oncol"],"DOI":"10.3892\/mco.2023.2675","type":"journal-article","created":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T10:33:02Z","timestamp":1692786782000},"source":"Crossref","is-referenced-by-count":1,"title":["Clinicopathological significance of concurrent ErbB receptor expression in human meningioma"],"prefix":"10.3892","volume":"19","author":[{"given":"Sverre","family":"Torp","sequence":"first","affiliation":[{"name":"Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, NO\u20117491 Trondheim, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magnus","family":"Arnli","sequence":"additional","affiliation":[{"name":"Department of Radiology, \u00d8stfold Hospital Trust, NO\u20111714 Gr\u00e5lum, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Scheie","sequence":"additional","affiliation":[{"name":"Department of Pathology, Copenhagen University Hospital, DK\u20112100 Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2023,8,23]]},"reference":[{"key":"key20231009094530_b1-MCO-19-4-02675","doi-asserted-by":"publisher","first-page":"iii1","DOI":"10.1093\/neuonc\/noac161","article-title":"CBTRUS statistical report: Pediatric brain tumor foundation childhood and adolescent primary brain and other central nervous system tumors diagnosed in the United States in 2014-2018","volume":"24(Suppl 3)","author":"Ostrom","year":"2022","journal-title":"Neuro Oncol"},{"key":"key20231009094530_b2-MCO-19-4-02675","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s11060-004-2749-0","article-title":"Molecular pathogenesis of meningiomas","volume":"70","author":"Perry","year":"2004","journal-title":"J Neurooncol"},{"issue":"S2","key":"key20231009094530_b3-MCO-19-4-02675","doi-asserted-by":"publisher","DOI":"10.21037\/cco.2017.05.02","article-title":"Classification of meningiomas-advances and controversies","volume":"6(Suppl 1)","author":"Harter","year":"2017","journal-title":"Chin Clin Oncol"},{"key":"key20231009094530_b4-MCO-19-4-02675","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s11060-010-0342-2","article-title":"Pathological classification and molecular genetics of meningiomas","volume":"99","author":"Mawrin","year":"2010","journal-title":"J Neurooncol"},{"key":"key20231009094530_b5-MCO-19-4-02675","doi-asserted-by":"publisher","first-page":"i4","DOI":"10.1093\/neuonc\/noy178","article-title":"Molecular and translational advances in meningiomas","volume":"21(Suppl 1)","author":"Suppiah","year":"2019","journal-title":"Neuro Oncol"},{"key":"key20231009094530_b6-MCO-19-4-02675","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s11060-010-0386-3","article-title":"Epidemiology and etiology of meningioma","volume":"99","author":"Wiemels","year":"2010","journal-title":"J Neurooncol"},{"key":"key20231009094530_b7-MCO-19-4-02675","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.2217\/fon-2018-0006","article-title":"An overview of meningiomas","volume":"14","author":"Buerki","year":"2018","journal-title":"Future Oncol"},{"key":"key20231009094530_b8-MCO-19-4-02675","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/cncr.33918","article-title":"Diagnostic, therapeutic, and prognostic implications of the 2021 World Health Organization classification of tumors of the central nervous system","volume":"128","author":"Gritsch","year":"2022","journal-title":"Cancer"},{"key":"key20231009094530_b9-MCO-19-4-02675","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO Classification of tumors of the central nervous system: A summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro Oncol"},{"key":"key20231009094530_b10-MCO-19-4-02675","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1093\/neuonc\/noab150","article-title":"EANO guideline on the diagnosis and management of meningiomas","volume":"23","author":"Goldbrunner","year":"2021","journal-title":"Neuro Oncol"},{"key":"key20231009094530_b11-MCO-19-4-02675","doi-asserted-by":"publisher","first-page":"i18","DOI":"10.1093\/neuonc\/noy136","article-title":"Advances in multidisciplinary therapy for meningiomas","volume":"21(Suppl 1)","author":"Brastianos","year":"2019","journal-title":"Neuro Oncol"},{"key":"key20231009094530_b12-MCO-19-4-02675","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.hoc.2012.04.007","article-title":"Complications of brain tumors and their treatment","volume":"26","author":"Lacy","year":"2012","journal-title":"Hematol Oncol Clin North Am"},{"key":"key20231009094530_b13-MCO-19-4-02675","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.jocn.2020.05.054","article-title":"How the elderly fare after brain tumor surgery compared to younger patients within a 30-day follow-up: A National surgical Quality Improvement Program analysis of 30,183 cases","volume":"78","author":"Nia","year":"2020","journal-title":"J Clin Neurosci"},{"key":"key20231009094530_b14-MCO-19-4-02675","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.phrs.2013.11.002","article-title":"The ErbB\/HER family of protein-tyrosine kinases and cancer","volume":"79","author":"Roskoski","year":"2014","journal-title":"Pharmacol Res"},{"issue":"a020768","key":"key20231009094530_b15-MCO-19-4-02675","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a020768","article-title":"The EGFR family: Not so prototypical receptor tyrosine kinases","volume":"6","author":"Lemmon","year":"2014","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"key20231009094530_b16-MCO-19-4-02675","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.yexmp.2007.12.002","article-title":"The status and role of ErbB receptors in human cancer","volume":"84","author":"Uberall","year":"2008","journal-title":"Exp Mol Pathol"},{"key":"key20231009094530_b17-MCO-19-4-02675","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-1-4939-7219-7_1","article-title":"ErbB receptors and cancer","volume":"1652","author":"Wang","year":"2017","journal-title":"Methods Mol Biol"},{"key":"key20231009094530_b18-MCO-19-4-02675","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/s0959-8049(01)00230-1","article-title":"The EGFR family and its ligands in human cancer. Signalling mechanisms and therapeutic opportunities","volume":"37 (Suppl 4)","author":"Yarden","year":"2001","journal-title":"Eur J Cancer"},{"key":"key20231009094530_b19-MCO-19-4-02675","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1152\/physiol.00045.2009","article-title":"Roles for growth factors in cancer progression","volume":"25","author":"Witsch","year":"2010","journal-title":"Physiology (Bethesda)"},{"issue":"152551","key":"key20231009094530_b20-MCO-19-4-02675","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2019.152551","article-title":"HER3 and HER4 are highly expressed in human meningiomas","volume":"215","author":"Arnli","year":"2019","journal-title":"Pathol Res Pract"},{"issue":"e0205846","key":"key20231009094530_b21-MCO-19-4-02675","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0205846","article-title":"Prognostic value of ErbB2\/HER2 in human meningiomas","volume":"13","author":"Arnli","year":"2018","journal-title":"PLoS One"},{"issue":"e3140","key":"key20231009094530_b22-MCO-19-4-02675","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.3140","article-title":"Expression and clinical value of EGFR in human meningiomas","volume":"5","author":"Arnli","year":"2017","journal-title":"PeerJ"},{"key":"key20231009094530_b23-MCO-19-4-02675","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s00401-004-0875-6","article-title":"Epidermal growth factor receptor family (EGFR, ErbB2-4) in gliomas and meningiomas","volume":"108","author":"Andersson","year":"2004","journal-title":"Acta Neuropathol"},{"key":"key20231009094530_b24-MCO-19-4-02675","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/j.jocn.2010.02.006","article-title":"Expression of ErbB-1 and ErbB-2 in meningioma","volume":"17","author":"Wickremesekera","year":"2010","journal-title":"J Clin Neurosci"},{"key":"key20231009094530_b25-MCO-19-4-02675","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1080\/07357900802709175","article-title":"Gene expression profiling of ErbB receptors and ligands in human meningiomas","volume":"27","author":"Laurendeau","year":"2009","journal-title":"Cancer Invest"},{"issue":"11352","key":"key20231009094530_b26-MCO-19-4-02675","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222111352","article-title":"Receptor tyrosine kinases as candidate prognostic biomarkers and therapeutic targets in meningioma","volume":"22","author":"Roesler","year":"2021","journal-title":"Int J Mol Sci"},{"key":"key20231009094530_b27-MCO-19-4-02675","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1111\/apm.12248","article-title":"Histopathology and prognosis in human meningiomas","volume":"122","author":"Backer-Grondahl","year":"2014","journal-title":"APMIS"},{"key":"key20231009094530_b28-MCO-19-4-02675","first-page":"231","article-title":"The histopathological spectrum of human meningiomas","volume":"5","author":"Backer-Grondahl","year":"2012","journal-title":"Int J Clin Exp Pathol"},{"key":"key20231009094530_b29-MCO-19-4-02675","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 World Health Organization classification of tumors of the central nervous system: A summary","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol"},{"key":"key20231009094530_b30-MCO-19-4-02675","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1097\/CCO.0000000000000687","article-title":"Molecular alterations in meningioma: Prognostic and therapeutic perspectives","volume":"32","author":"Birzu","year":"2020","journal-title":"Curr Opin Oncol"},{"key":"key20231009094530_b31-MCO-19-4-02675","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nrneurol.2017.168","article-title":"Advances in meningioma genetics: Novel therapeutic opportunities","volume":"14","author":"Preusser","year":"2018","journal-title":"Nat Rev Neurol"},{"key":"key20231009094530_b32-MCO-19-4-02675","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1111\/neup.12266","article-title":"Activation of multiple growth factor signalling pathways is frequent in meningiomas","volume":"36","author":"Hilton","year":"2016","journal-title":"Neuropathology"},{"key":"key20231009094530_b33-MCO-19-4-02675","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/1878-0261.12155","article-title":"Emerging functions of the EGFR in cancer","volume":"12","author":"Sigismund","year":"2018","journal-title":"Mol Oncol"},{"key":"key20231009094530_b34-MCO-19-4-02675","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3171\/jns.1997.87.2.0315","article-title":"Expression and activation of epidermal growth factor receptors in meningiomas","volume":"87","author":"Carroll","year":"1997","journal-title":"J Neurosurg"},{"issue":"F1000 Faculty Rev-2270","key":"key20231009094530_b35-MCO-19-4-02675","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.9025.1","article-title":"EGF receptor ligands: Recent advances","volume":"5","author":"Singh","year":"2016","journal-title":"F1000Res"},{"key":"key20231009094530_b36-MCO-19-4-02675","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1080\/08977190600634373","article-title":"Control of ErbB signaling through metalloprotease mediated ectodomain shedding of EGF-like factors","volume":"24","author":"Sanderson","year":"2006","journal-title":"Growth Factors"},{"key":"key20231009094530_b37-MCO-19-4-02675","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3109\/08977194.2011.649918","article-title":"EGFR ligands exhibit functional differences in models of paracrine and autocrine signaling","volume":"30","author":"Wilson","year":"2012","journal-title":"Growth Factors"},{"key":"key20231009094530_b38-MCO-19-4-02675","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41568-020-00322-0","article-title":"Antitumour immunity regulated by aberrant ERBB family signalling","volume":"21","author":"Kumagai","year":"2021","journal-title":"Nat Rev Cancer"},{"key":"key20231009094530_b39-MCO-19-4-02675","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/nrm1962","article-title":"EGF-ERBB signalling: Towards the systems level","volume":"7","author":"Citri","year":"2006","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1523","key":"key20231009094530_b40-MCO-19-4-02675","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.01523","article-title":"An overview of managements in meningiomas","volume":"10","author":"Zhao","year":"2020","journal-title":"Front Oncol"},{"issue":"851758","key":"key20231009094530_b41-MCO-19-4-02675","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.851758","article-title":"Identification and management of aggressive meningiomas","volume":"12","author":"Patel","year":"2022","journal-title":"Front Oncol"},{"issue":"76","key":"key20231009094530_b42-MCO-19-4-02675","doi-asserted-by":"publisher","DOI":"10.21037\/cco-2020-mbt-01","article-title":"A narrative review of targeted therapies in meningioma","volume":"9","author":"Kim","year":"2020","journal-title":"Chin Clin Oncol"},{"key":"key20231009094530_b43-MCO-19-4-02675","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.critrevonc.2010.12.005","article-title":"Current technologies for HER2 testing in breast cancer","volume":"80","author":"Moelans","year":"2011","journal-title":"Crit Rev Oncol Hematol"},{"key":"key20231009094530_b44-MCO-19-4-02675","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1016\/j.prp.2017.09.021","article-title":"EGFR immunohistochemistry as biomarker for antibody-based therapy of squamous NSCLC-Experience from the first ring trial of the German Quality Assurance Initiative for Pathology (QuIP\u00ae)","volume":"213","author":"Petersen","year":"2017","journal-title":"Pathol Res Pract"},{"key":"key20231009094530_b45-MCO-19-4-02675","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1016\/j.yexcr.2008.09.027","article-title":"Trafficking of receptor tyrosine kinases to the nucleus","volume":"315","author":"Carpenter","year":"2009","journal-title":"Exp Cell Res"},{"issue":"13","key":"key20231009094530_b46-MCO-19-4-02675","doi-asserted-by":"publisher","DOI":"10.1186\/2045-3701-2-13","article-title":"Nuclear functions and subcellular trafficking mechanisms of the epidermal growth factor receptor family","volume":"2","author":"Wang","year":"2012","journal-title":"Cell Biosci"},{"key":"key20231009094530_b47-MCO-19-4-02675","first-page":"139","article-title":"Prognostic value of EGFR expression in de novo and progressed atypical and anaplastic meningiomas: An immunohistochemical and fluorescence in situ hybridization pilot study","volume":"57","author":"Caltabiano","year":"2013","journal-title":"J Neurosurg Sci"},{"key":"key20231009094530_b48-MCO-19-4-02675","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1111\/j.1699-0463.1992.tb04002.x","article-title":"Expression of epidermal growth factor receptor in human meningiomas and meningeal tissue","volume":"100","author":"Torp","year":"1992","journal-title":"APMIS"},{"key":"key20231009094530_b49-MCO-19-4-02675","doi-asserted-by":"publisher","first-page":"741","DOI":"10.14670\/HH-18-195","article-title":"Next generation sequencing identifies novel potential actionable mutations for grade I meningioma treatment","volume":"35","author":"Pepe","year":"2020","journal-title":"Histol Histopathol"},{"key":"key20231009094530_b50-MCO-19-4-02675","first-page":"153","article-title":"Embryonic and fetal development of structures associated with the cerebro-spinal fluid in man and other species. Part I: The ventricular system, meninges and choroid plexuses","volume":"46","author":"Catala","year":"1998","journal-title":"Arch Anat Cytol Pathol"},{"key":"key20231009094530_b51-MCO-19-4-02675","first-page":"353","article-title":"Coexpression of c-erbB 1-4 receptor proteins in human glioblastomas. An immunohistochemical study","volume":"26","author":"Torp","year":"2007","journal-title":"J Exp Clin Cancer Res"},{"key":"key20231009094530_b52-MCO-19-4-02675","doi-asserted-by":"publisher","first-page":"2907","DOI":"10.1016\/j.yexcr.2008.07.013","article-title":"Shedding of epidermal growth factor receptor is a regulated process that occurs with overexpression in malignant cells","volume":"314","author":"Perez-Torres","year":"2008","journal-title":"Exp Cell Res"},{"key":"key20231009094530_b53-MCO-19-4-02675","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1016\/0959-8049(93)90305-y","article-title":"C-erbB-2\/HER-2 protein in human intracranial tumours","volume":"29A","author":"Torp","year":"1993","journal-title":"Eur J Cancer"},{"key":"key20231009094530_b54-MCO-19-4-02675","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1081\/cnv-200026523","article-title":"Determination of HER-2\/neu overexpression and clinical predictors of survival in a cohort of 347 patients with primary malignant brain tumors","volume":"22","author":"Potti","year":"2004","journal-title":"Cancer Invest"},{"key":"key20231009094530_b55-MCO-19-4-02675","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.humpath.2005.12.020","article-title":"Prognostic value of HER2 expression in meningiomas: An immunohistochemical and fluorescence in situ hybridization study","volume":"37","author":"Loussouarn","year":"2006","journal-title":"Hum Pathol"},{"key":"key20231009094530_b56-MCO-19-4-02675","doi-asserted-by":"publisher","first-page":"526","DOI":"10.4103\/0976-3147.188640","article-title":"Human epidermal growth factor receptor 2\/neu protein expression in meningiomas: An immunohistochemical study","volume":"7","author":"Telugu","year":"2016","journal-title":"J Neurosci Rural Pract"},{"key":"key20231009094530_b57-MCO-19-4-02675","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/BF00228582","article-title":"Expression of the c-erbB-2-encoded oncoprotein and progesterone receptor in human meningiomas","volume":"86","author":"Schlegel","year":"1993","journal-title":"Acta Neuropathol"},{"key":"key20231009094530_b58-MCO-19-4-02675","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3109\/02688698808992672","article-title":"Amplification of the epidermal growth factor receptor gene in biopsy specimens from human intracranial tumours","volume":"2","author":"Helseth","year":"1988","journal-title":"Br J Neurosurg"},{"key":"key20231009094530_b59-MCO-19-4-02675","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/nrc3309","article-title":"The ERBB network: At last, cancer therapy meets systems biology","volume":"12","author":"Yarden","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"key20231009094530_b60-MCO-19-4-02675","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1007\/s12282-013-0478-y","article-title":"Prognostic value of phosphorylated HER2 in HER2-positive breast cancer patients treated with adjuvant trastuzumab","volume":"22","author":"Kurebayashi","year":"2015","journal-title":"Breast Cancer"},{"key":"key20231009094530_b61-MCO-19-4-02675","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.lungcan.2014.10.014","article-title":"HER2 gene mutations in non-small cell lung carcinomas: Concurrence with Her2 gene amplification and Her2 protein expression and phosphorylation","volume":"87","author":"Suzuki","year":"2015","journal-title":"Lung Cancer"},{"key":"key20231009094530_b62-MCO-19-4-02675","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/nan.12487","article-title":"Genomic profiling of anaplastic meningioma identifies recurrent genetic alterations with relevance to lower-grade meningioma","volume":"45","author":"Cimino","year":"2019","journal-title":"Neuropathol Appl Neurobiol"},{"key":"key20231009094530_b63-MCO-19-4-02675","doi-asserted-by":"publisher","first-page":"3528","DOI":"10.1158\/1078-0432.CCR-20-4465","article-title":"Thirty years of HER3: From basic biology to therapeutic interventions","volume":"27","author":"Haikala","year":"2021","journal-title":"Clin Cancer Res"},{"issue":"7376","key":"key20231009094530_b64-MCO-19-4-02675","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26237376","article-title":"A Review of HER4 (ErbB4) kinase, its impact on cancer, and its inhibitors","volume":"26","author":"El-Gamal","year":"2021","journal-title":"Molecules"},{"key":"key20231009094530_b65-MCO-19-4-02675","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1158\/1078-0432.CCR-22-2085","article-title":"Pharmacological landscape of FDA-Approved anticancer drugs reveals sensitivities to ixabepilone, romidepsin, omacetaxine, and carfilzomib in aggressive meningiomas","volume":"29","author":"Jungwirth","year":"2023","journal-title":"Clin Cancer Res"},{"key":"key20231009094530_b66-MCO-19-4-02675","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1016\/j.cell.2023.02.038","article-title":"SnapShot: Cancer chemotherapy","volume":"186","author":"Falzone","year":"2023","journal-title":"Cell"}],"container-title":["Molecular and Clinical Oncology"],"original-title":[],"deposited":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T08:25:35Z","timestamp":1696839935000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/mco.2023.2675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,23]]},"references-count":66,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,8,23]]}},"URL":"https:\/\/doi.org\/10.3892\/mco.2023.2675","relation":{},"ISSN":["2049-9450","2049-9469"],"issn-type":[{"value":"2049-9450","type":"print"},{"value":"2049-9469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,23]]},"article-number":"79"}}